Latest Strategic Partnerships News

Spacetalk Ltd reveals a successful pivot to a software-led, hardware-enabled model, reporting 12% revenue growth and expanding into 15 international markets. The company targets $20–25 million in recurring revenue for 2026, underpinned by new product launches and strategic telco partnerships.

Eagle Mountain Mining has reapplied for two cancelled exploration permits covering 12% of its Silver Mountain Project, with no expected disruption to near-term activities.

Stakk Limited has secured a strategic multi-year partnership with Stride Bank, a 110-year-old U.S. institution, further accelerating its annualised recurring revenue and broadening its footprint across American financial sectors.

Tivan Limited has dispatched its inaugural acid grade fluorspar samples from the Speewah Fluorite Project to potential buyers in Japan and Asia, marking a significant step in its offtake marketing program led by Sumitomo Corporation.

Activeport Group has signed nine new channel partners for its Global Edge platform, boosting its recurring revenue potential and challenging legacy players in Australia’s enterprise networking market.

AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.

Finbar Group Limited highlights strong sales momentum in 2025, underpinned by a $1.2 billion development pipeline and a buoyant Western Australian apartment market driven by migration and undersupply.

EVE Health Group has partnered with telehealth provider hubMed to deliver a national patient support program, enhancing care continuity for users of its women’s and men’s health products Dyspro™ and Libbo™.

Mount Hope Mining has withdrawn its recently announced Share Purchase Plan, citing challenging market conditions. Shareholders will receive full refunds within days.

Bio-Gene Technology Limited updates on its development of two novel insecticides, Flavocide and Qcide, highlighting regulatory progress, commercial partnerships, and a strong market outlook across multiple sectors.

Stakk Limited's trading suspension has been lifted following the announcement of a finalized agreement for a significant new customer contract, signaling renewed investor confidence.

EML Payments has affirmed its FY26 underlying EBITDA guidance of A$58-63 million following a solid Q1 trading update, underpinned by a growing new program pipeline and operational efficiencies.